Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.
第一作者:
Scott M,Haake
第一单位:
Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. Electronic address: Scott.M.Haake@Vanderbilt.edu.
作者:
医学主题词
老年人(Aged);癌, 肾细胞(Carcinoma, Renal Cell);共病现象(Comorbidity);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤转移(Neoplasm Metastasis);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);预后(Prognosis);回顾性研究(Retrospective Studies);存活率(Survival Rate)
DOI
10.1016/j.urolonc.2015.09.015
PMID
26546482
发布时间
2024-06-10
- 浏览57
Urologic oncology
122.e1-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



